Terms: = Chronic Myelogenous Leukemia AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
3 results:
1. Inhibition of 32Dp210 cells harboring T315I mutation by a novel derivative of emodin correlates with down-regulation of BCR-ABL and its downstream signaling pathways.
Li J; Chen Y; Chen B; Chen C; Qiu B; Zheng Z; Zheng J; Liu T; Wang W; Hu J
J Cancer Res Clin Oncol; 2015 Feb; 141(2):283-93. PubMed ID: 25217883
[TBL] [Abstract] [Full Text] [Related]
2. The rate of apoptosis and expression of bcl-2 and Bax in leukocytes of acute myeloblastic leukemia patients.
Dabrowska M; Pietruczuk M; Kostecka I; Suchowierska M; Kloczko J; Nasilowska B; Bany-Laszewicz U; Marianska B
Neoplasma; 2003; 50(5):339-44. PubMed ID: 14628086
[TBL] [Abstract] [Full Text] [Related]
3. Absolute levels of MDR-1, MRP, and bcl-2 MRNA and tumor remission in acute leukemia.
Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
[TBL] [Abstract] [Full Text] [Related]
